Daniel b. Drachman
#114,633
Most Influential Person Now
Daniel b. Drachman's AcademicInfluence.com Rankings
Daniel b. Drachmanmedical Degrees
Medical
#1620
World Rank
#1978
Historical Rank
Neurology
#142
World Rank
#208
Historical Rank
Download Badge
Medical
Why Is Daniel b. Drachman Influential?
(Suggest an Edit or Addition)Daniel b. Drachman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis (1990) (646)
- Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors (1973) (591)
- Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. (1977) (437)
- Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. (1978) (382)
- Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. (1982) (363)
- The role of movement in embryonic joint development (1966) (329)
- Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS (2002) (308)
- Trial of celecoxib in amyotrophic lateral sclerosis (2006) (271)
- Botulinum toxin: mechanism of presynaptic blockade. (1976) (262)
- Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases (2001) (255)
- Effects of aging on nerve sprouting and regeneration (1980) (254)
- Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. (1977) (246)
- Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. (1977) (241)
- Myasthenia Gravis and the Thyroid Gland (1962) (239)
- Multifocal motor neuropathy: Response to human immune globulin (1993) (225)
- Nerve conduction studies in amyotrophic lateral sclerosis (1992) (191)
- "Myopathic" changes in chronically denervated muscle. (1967) (184)
- Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. (1974) (183)
- Experimental clubfoot and arthrogryposis multiplex congenita. (1962) (179)
- The role of movement in the development of joints and related structures: the head and neck in the chick embryo. (1969) (168)
- Effect of muscle disuse on acetylcholine receptors (1976) (163)
- A new stain for quantitative measurement of sprouting at neuromuscular junctions (1978) (155)
- Trophic Regulation of Acetylcholine Sensitivity of Muscle: Effect of Electrical Stimulation (1972) (147)
- Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. (1987) (146)
- Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis (1988) (145)
- Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. (1989) (141)
- Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. (1997) (139)
- Motor nerve sprouting and acetylcholine receptors. (1978) (134)
- Treatment of refractory myasthenia: “Rebooting” with high‐dose cyclophosphamide (2003) (129)
- A genome-wide association study of myasthenia gravis. (2015) (124)
- Clinical comparison of muscle‐specific tyrosine kinase (MuSK) antibody‐positive and ‐negative myasthenic patients (2004) (122)
- Inhibition of cyclooxygenase‐2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis (2000) (118)
- Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. (1978) (112)
- Humoral Pathogenesis of Myasthenia Grayis a (1987) (110)
- Arthrogryposis multiplex congenita. Case due to disease of the anterior horn cells. (1961) (107)
- The biology of myasthenia gravis. (1981) (106)
- Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis (1994) (105)
- Mechanisms of acetylcholine receptor loss in myasthenia gravis. (1980) (105)
- Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis (1989) (103)
- Rebooting the Immune System with High‐Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis (2008) (98)
- PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY (1974) (98)
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation (1994) (97)
- Fast axonal transport in motor nerve regeneration. (1976) (97)
- Excitatory amino acids in amyotrophic lateral sclerosis: An update (1991) (93)
- Head drop and camptocormia (2002) (85)
- Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. (2008) (85)
- THE PATHOGENESIS OF REACTIVE AXONAL SWELLINGS: ROLE OF AXONAL TRANSPORT (1977) (84)
- Trophic functions of the neuron (1974) (83)
- Atrophy of Skeletal Muscle in Chick Embryos Treated with Botulinum Toxin (1964) (79)
- Ocular pseudomyasthenia or ocular myasthenia 'plus': a warning to clinicians. (1989) (78)
- Amyotrophic lateral sclerosis: An unconventional autoimmune disease? (1989) (78)
- Blockade of acetylcholine receptors: a model of myasthenia gravis. (1975) (77)
- Myeloma neuropathy. Successful treatment of two patients and review of cases. (1972) (77)
- THE ROLE OF ACETYLCHOLINE AS A NEUROTROPHIC TRANSMITTER * (1974) (76)
- Neurotrophic regulation of two properties of skeletal muscle by impulse- dependent and spontaneous acetylcholine transmission (1982) (75)
- Neurotrophic regulation of muscle cholinesterase: effects of botulinum toxin and denervation (1972) (73)
- Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design (2006) (73)
- Impaired axonal regeneration in acrylamide intoxication. (1977) (70)
- Measurement of junctional acetylcholine receptors in myasthenia gravis: Clinical correlates (1985) (67)
- Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junction (1983) (66)
- Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. (1978) (66)
- Combined short‐term immunotherapy for experimental autoimmune myasthenia gravis (1983) (62)
- Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy (2018) (59)
- Lithium reduces the number of acetylcholine receptors in skeletal muscle. (1980) (56)
- Is acetylcholine the trophic neuromuscular transmitter? (1967) (55)
- Botulinum Toxin as a Tool for Research on the Nervous System (1971) (52)
- Development of a mammalian fast muscle: dynamic and biochemical properties correlated (1973) (52)
- MYASTHENIA GRAVIS AS A RECEPTOR DISORDER (1976) (50)
- Effect of botulinum toxin on trophic regulation of acetycholine receptors (1976) (50)
- Denervation accelerates the degradation of junctional acetylcholine receptors (1981) (50)
- Treatment of experimental myasthenia gravis with cyclosporin A. (1985) (48)
- Membrane myopathy: Morphological similarities to duchenne muscular dystrophy (1982) (48)
- The effect of disuse on cholinergic enzymes. (1978) (48)
- Periodic alteration of consciousness in the "pickwickian" syndrome. (1962) (47)
- Rapid degradation of "new" acetylcholine receptors at neuromuscular junctions. (1983) (47)
- Oral Tolerance in Myasthenia Gravis a (1996) (46)
- Motor nerve terminal outgrowth and acetylcholine receptors: inhibition of terminal outgrowth by alpha-bungarotoxin and anti-acetylcholine receptor antibody (1985) (43)
- Alcoholic rhabdomyolysis: an experimental model in the rat. (1980) (43)
- Cholinergic transmission regulates extrajunctional acetylcholine receptors (1980) (43)
- Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis. (1982) (40)
- Autonomic "myasthenia": the case for an autoimmune pathogenesis. (2003) (40)
- Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders (1989) (40)
- The oculopharyngeal syndrome. (1968) (39)
- Immunotherapy in neuromuscular disorders: Current and future strategies (1996) (39)
- How subtle differences in MHC class II affect the severity of experimental myasthenia gravis. (1998) (36)
- Myasthenia gravis: immunobiology of a receptor disorder (1983) (35)
- Neurotrophic regulation of dynamic properties of skeletal muscle: effects of botulinum toxin and denervation. (1975) (35)
- Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-Diphtheria toxin fusion protein (1998) (35)
- Calcium Transport in Isolated Sarcoplasmic Reticulum during Muscle Maturation (1968) (34)
- High-Dose Cyclophosphamide Without Stem Cell Rescue in 207 Patients With Aplastic Anemia and Other Autoimmune Diseases (2011) (34)
- Development of a mammalian fast muscle: dynamic and biochemical properties correlated. (1973) (33)
- Autoantibodies to acetylcholine receptors in myasthenia gravis. (1983) (33)
- Granzyme B: Evidence for a role in the origin of myasthenia gravis (2008) (33)
- Myasthenia gravis (second of two parts). (1978) (33)
- IDENTICAL MITOCHONDRIAL DNA DELETION IN BLOOD AND MUSCLE (1989) (33)
- Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis. (1986) (32)
- Myasthenia gravis: biology and treatment. (1987) (31)
- ANTIBODY‐MEDIATED MECHANISMS OF ACh RECEPTOR LOSS IN MYASTHENIA GRAVIS: CLINICAL RELEVACE * (1981) (31)
- How to recognize an antibody-mediated autoimmune disease: criteria. (1990) (31)
- Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy (2011) (31)
- Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis. (1995) (30)
- EXPERIMENTAL ACETYLCHOLINE BLOCKADE OF THE NEUROMUSCULAR JUNCTION. EFFECTS ON END PLATE AND MUSCLE FIBER ULTRASTRUCTURE * (1976) (30)
- Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle. (1993) (30)
- Dimethyl sulphoxide reduces anti-receptor antibody titres in experimental myasthenia gravis (1980) (30)
- Experimental arthrogryposis caused by viral myopathy. (1976) (30)
- Spin‐label studies of erythrocytes in myotonic dystrophy (1980) (29)
- Present and future treatment of myasthenia gravis. (1987) (29)
- Branched‐chain ketoacids reduce muscle protein degradation in duchenne muscular dystrophy (1982) (29)
- Strategies for the Treatment of Myasthenia Gravis (1988) (28)
- Gangliosides elicit a T-cell independent antibody response. (1993) (28)
- Attempts to implicate viruses in myasthenia gravis (1985) (28)
- Denervation and the time course of resting membrane potential changes in skeletal muscle in vivo (1980) (28)
- AXONAL TRANSPORT TO AND FROM THE MOTOR NERVE ENDING * (1976) (27)
- Method for Continuous Infusion of Fluids into the Chorioallantoic Circulation of the Chick Embryo (1962) (27)
- Are muscle fibers denervated in myotonic dystrophy? (1976) (26)
- Regeneration in botulinum-poisoned forelimbs of the newt, Triturus. (1971) (26)
- Specific Immunotherapy by Genetically Engineered APCs: The “Guided Missile” Strategy1 (2001) (26)
- The pathophysiology of penicillamine‐induced myasthenia gravis (1986) (26)
- NEUROMUSCULAR TRANSMISSION OF TROPHIC EFFECTS * (1971) (24)
- A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in ‘antibody-negative’ myasthenia gravis (1990) (23)
- Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases. (2013) (23)
- Therapy of Myasthenia Gravis and Myasthenic Syndromes (2003) (23)
- Heteroplasmy in Chronic External Ophthalmoplegia: Clinical and Molecular Observations (1990) (22)
- Corneal decompensation in mitochondrial ophthalmoplegia plus (Kearns-Sayre) syndrome. A clinicopathologic case report. (1994) (22)
- Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies (1983) (22)
- Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide (1982) (22)
- 3-deaza-adenosine and inhibition of HIV (1992) (22)
- Isaacs syndrome with laryngeal involvement (1979) (22)
- Factors That Determine the Severity of Experimental Myasthenia Gravisa a (1998) (21)
- High-dose therapy for autoimmune neurologic diseases (2005) (20)
- Silver cholinesterase immunocytochemistry: A new neuromuscular junction stain (1989) (20)
- Amyotrophic lateral sclerosis and antibodies to voltage‐gated calcium channels—new doubts (1996) (19)
- Motor nerve outgrowth: reduced capacity for sprouting in the terminals of longer axons (1988) (19)
- Psychiatric Effects of Alternate Day Steroid Therapy (1981) (19)
- The syndrome of arthrogryposis multiplex congenita. (1971) (19)
- Amyotrophic lateral sclerosis. An autoimmune disease? (1995) (18)
- Targeting antigen-specific T cells by genetically engineered antigen presenting cells A strategy for specific immunotherapy of autoimmune disease (2000) (17)
- Inhibition of methyltransferase reduces the turnover of acetylcholine receptors. (1988) (17)
- Tolerance to acetylcholine receptor induced by AChR-coupled syngeneic cells (1992) (17)
- TROPHIC ACTIONS OF THE NEURON: AN INTRODUCTION (1974) (17)
- Polymyositis: Reduction of acetylcholine receptors in skeletal muscle (1985) (17)
- Specific immunotherapy of experimental myasthenia gravis in vitro: the "guided missile" strategy. (2001) (17)
- The developing motor end‐plate: pharmacological studies in the chick embryo (1963) (17)
- 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors. (1993) (16)
- Stabilization of acetylcholine receptors at the neuromuscular synapse: the role of the nerve (1992) (16)
- Myasthenia gravis (first of two parts). (1978) (15)
- Effect of neuromuscular blockade on enzymatic activities of muscles. (1970) (15)
- Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis (1980) (15)
- Antigen-specific suppressor macrophages induced by culture with cyclosporine A plus acetylcholine receptor (1989) (15)
- Cholinergic stimulation of skeletal muscle cells induces rapid immediate early gene expression: role of intracellular calcium. (1994) (15)
- Effect of botulinum toxin on trophic regulation of acetylcholine receptors. (1976) (15)
- Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study (2022) (15)
- Effect of botulinum toxin on speed of skeletal muscle contraction. (1969) (15)
- Neural regulation of mRNA for the α-subunit of acetylcholine receptors: Role of neuromuscular transmission (1989) (14)
- Effect of disuse on the resting membrane potential of skeletal muscle (1979) (14)
- Suppression of immune responses to acetylcholine receptor by interleukin 2-fusion toxin: in vivo and in vitro studies (1991) (14)
- Specific Immunotherapy of Experimental Myasthenia by Genetically Engineered APCs (2003) (14)
- Therapy of myasthenia gravis. (2008) (14)
- T-cell vaccination in experimental myasthenia gravis: a double-edged sword. (1990) (14)
- The effects of nerve section on the non-quantal release of ACh from the motor nerve terminal (1986) (13)
- Gene transfer of baculoviral p35 by adenoviral vector protects human cerebral neurons from apoptosis. (2004) (13)
- Strategies for Treatment of Myasthenia Gravis a (1993) (13)
- The effect of thalidomide on experimental autoimmune myasthenia gravis. (1989) (13)
- Treatment of experimental myasthenia gravis with total lymphoid irradiation. (1988) (13)
- Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor (2005) (13)
- “Sero-negative” Myasthenia Gravis: A Humorally Mediated Variant of Myasthenia (1987) (13)
- Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulinum toxin and denervation. (1984) (12)
- Stabilization of Acetylcholine Receptors at Neuromuscular Junctions: Analysis by Specific Antibodies a (1987) (11)
- Internalization of IgG in motoneurons of patients with ALS (1995) (11)
- Induction of apoptosis in activated T cell blasts by suppressive macrophages: a possible immunotherapeutic approach for treatment of autoimmune disease. (1999) (11)
- The effect of botulinum toxin on uptake of calcium by synaptosomes (1969) (11)
- Myasthenia gravis: a model disorder of acetylcholine receptors. (1987) (10)
- Mechanism of action of lithium on acetylcholine receptor metabolism in skeletal muscle (1987) (10)
- Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America (2020) (9)
- Reduced acetylcholine receptors in myasthenia gravis. (1973) (9)
- Prednisone Schedule for Myasthenia Gravis (1974) (9)
- Failure of isoprinosine in amyotropic lateral sclerosis. (1971) (8)
- Properties of Suppressor Cells Induced to Acetylcholine Receptor Using Cyclosporin A a (1987) (8)
- A Novel Therapy for Myasthenia Gravis by Reducing the Endocytosis of Acetylcholine Receptors a (1993) (7)
- Total lymphoid irradiation and antigen-specific tolerance: future therapy for experimental myasthenia gravis? (1990) (7)
- Immunopathology of myasthenia gravis. (1979) (7)
- Effects of dimethyl sulfoxide on humoral immune responses to acetylcholine receptors in the rat. (1985) (7)
- Strategy for Treating Motor Neuron Diseases Using a Fusion Protein of Botulinum Toxin Binding Domain and Streptavidin for Viral Vector Access: Work in Progress (2010) (7)
- Phospholipid methylation in skeletal muscle membranes (1985) (7)
- The effect of aging on nerve sprouting. (1978) (6)
- Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy (2022) (6)
- Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors. (1979) (5)
- Acetylcholine Receptors and Myasthenia Gravis (1979) (5)
- Partial T-cell receptor gene rearrangement. A source of pseudo-clonal populations in thymomas and other thymic tissues. (1996) (5)
- Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: The Guided Missile strategy (2012) (5)
- Comment: Methotrexate for patients with generalized myasthenia gravis (2016) (5)
- Pharmacological denervation of skeletal muscle in chick embryos treated with botulinum toxin. (1965) (4)
- Disorders of neuromuscular junction transmission (2002) (4)
- Book Review Myasthenia Gravis: An Illustrated History By John C. Keesey. 113 pp., illustrated. Roseville, Calif., Publishers Design Group, 2002. (Distributed by the Myasthenia Gravis Foundation of America, Los Angeles.) $49.95. 1-929170-04-1 (2003) (4)
- T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor (2002) (4)
- Effect of myasthenic immunoglobulin on ACh receptors of cultured muscle. (1977) (4)
- [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)]. (1976) (4)
- Blind evaluation of lymphocyte capping in Duchenne muscular dystrophy (1984) (4)
- Therapeutic strategies in experimental autoimmune myasthenia gravis. (1981) (4)
- Rapid synthesis of acetylcholine receptors at neuromuscular junctions (1988) (4)
- Antibody‐Mediated Membrane Abnormalities in Polymyositis: Reduction of Acetylcholine Receptors by Immunoglobulin (1987) (4)
- The developing motor end‐plate: curare tolerance in the chick embryo. (1965) (4)
- Failure of isoprinosine in amyotrophic lateral sclerosis. (1971) (4)
- Neuromuscular junction as Achilles' heel (2014) (3)
- THERAPEUTIC STRATEGIES IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS * (1981) (3)
- Critical reexamination of the thymus immunization model of myasthenia gravis (1980) (3)
- Acetylcholine Receptor Presentation by B Cells Using Heterobifunctional Antibody Conjugates a (1993) (3)
- The Role of Acetylcholine as a Trophic Neuromuscular Transmitter (2008) (3)
- Effect of ketoleucine treatment on atrophy of skeletal muscle (1988) (2)
- Ocular pseudomyasthenia or ocular my asthenia 'plus' (1989) (2)
- Treatment of experimental autoimmune myasthenia gravis (EAMG) using single, high-dose cyclophosphamide (1980) (2)
- Treatment for Refractory Myasthenia Gravis-New Lymphs for Old. (2016) (2)
- Targeting T cells in myasthenia gravis (1999) (2)
- Adventures in clinical and basic science. (2003) (2)
- Residents essay award: low-dose-rate total lymphoid irradiation: A new method of rapid immunosuppression (1987) (2)
- Design and Preliminary Evaluation of an Augmented Reality Interface Control System for a Robotic Arm (2020) (1)
- 901. Targeting of Viral Vectors to Motor Neurons by Botulinum Toxin Binding Domain To Treat ALS (2006) (1)
- Neural regulation of MRNA for the alpha-subunit of acetylcholine receptors: Role of neuromuscular transmission. (Reannouncement with new availability information) (1989) (1)
- Autoimmunity and ALS. Discussion (1996) (1)
- Advances in myasthenia gravis proceedings of the myasthenia gravis foundation medical advisory board, New york, NY, december 3, 1982 (1983) (1)
- Trophic functions of the neuron. 3. Mechanisms of neurotrophic interactions. The role of acetylcholine as a neurotropic transmitter. (1974) (1)
- Turnover of Acetylcholine Receptors: Mechanisms of Regulation (1987) (1)
- 10 MOST COMMONLY ASKED QUESTIONS ABOUT MYASTHENIA GRAVIS (1999) (1)
- Low-dose-rate total lymphoid irradiation: a new method of rapid immunosuppression. (1987) (1)
- tects motor neurons in culture from excitotoxic cell death 10 and prolongs survival in the mutant SOD 1 mouse model (2006) (0)
- Performance hand cramps in a violinist, remitting with quinine sulfate: A case report (1996) (0)
- Newer Treatments for Myasthenia Gravis: 2020 Update (2021) (0)
- A Synaptic System: Plasticity of the Neuromuscular System . David Evered and Julie Whelan, Eds. Wiley-Interscience, New York, 1988. x, 273 pp., illus. $54.95. Ciba Foundation Symposium, vol. 138. From a symposium, London, U.K., Jan. 1988. (1989) (0)
- Quantitative psychiatric assessment of patients with myasthenia gravis (1983) (0)
- Tolerance to A ChR Induced by A ChR‐Coupled Syngeneic Cells: Clonal Anergy? a (1993) (0)
- Reply (1994) (0)
- Plasmapheresis and the immunobiology of myasthenia gravis. Editpd by Peter C. Dau, 371 pp, illus, Houghton Mifflin professional publishers, bosloii, MA, 1979. $35.00 (1980) (0)
- Adrenal Corticosteroids Provide Long-Term Benefit in Duchenne Muscular Dystrophy (2018) (0)
- Surgical Approaches to Thymectomy in Myasthenia Gravis (2021) (0)
- Production and Characterization of a T Cell Receptor Transgenic Mouse Recognizing the Immunodominant Epitope of the Torpedo californica Acetylcholine Receptor (2003) (0)
- Treatment of Duchenne Muscular Dystrophy with a New Corticosteroid Agent (2019) (0)
- DMSO and immunity (1981) (0)
- Therapeutic Strategies for Protein Wasting States (1983) (0)
- Efgartigimod: PLEX in a Bottle — A Quick Fix for Myasthenia Gravis (2021) (0)
- Advances in myasthenia gravis proceedings of the myasthenia gravis foundation medical advisory board, New York, NY, December 2, 1983 (1984) (0)
- How Not to Miss Congenital Myasthenic Syndromes in Adults (2018) (0)
- AGenome-Wide Association Study ofMyasthenia Gravis (2015) (0)
- The Ice Test in Myasthenia Gravis: Who Should Do it, When, and Why? (2020) (0)
- Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis (2022) (0)
- Plasticity of the Neuromuscular System. David Evered and Julie Whelan, Eds. Wiley-Interscience, New York, 1988. x, 273 pp., illus. $54.95. Ciba Foundation Symposium, vol. 138. From a symposium, London, U.K., Jan. 1988. (1989) (0)
- Motor nerve terminal sprouting and acetylcholine (ACh) receptors (1978) (0)
- NEW AND OLD STRATEGIES IN THE TREATMENT OF MYASTHENIA GRAVIS (2006) (0)
- High Dose Cyclophosphamide (HD CY) without Hematopoietic Stem Cell Transplantation (HSCT) in Refractory Severe Autoimmune Diseases: 11 Year Experience in Over 100 Patients. (2009) (0)
- Reply (1993) (0)
- Myasthenia gravis. Passive transfer from man to mice with immunoglobulins. Abstr. (1976) (0)
- Author response. (2015) (0)
- Molecular Mimicry andMyasthenia Gravis AnAutoantigenic SiteoftheAcetylcholine Receptor a-Subunit ThatHasBiologic Activity andReactsImmunochemically withHerpes Simplex Virus (1989) (0)
- Congress Schedule (1998) (0)
- Is Exon-Skipping Eteplirsen Useful for Treating Duchenne Muscular Dystrophy? (2018) (0)
- MuSK Antibodies in Myasthenia Gravis: An Uncertain Pathogenic Role (2004) (0)
- JAMA Neurology Peer Reviewers in 2016. (2017) (0)
- Structure-function relations of the thyrotropin receptor - discussion (1982) (0)
- Advances in myasthenia gravis, proceedings of the myasthenia gravis foundation medical advisory board, New York, NY, December 4, 1981 (1982) (0)
- Total lymphoid irradiation, an immunosuppressant in graft tolerance: conventional vs. low-dose-rate irradiation (1986) (0)
- GENERAL DISCUSSION (1974) (0)
- Might Heart-Derived Cell Infusion Benefit Patients with Duchenne Muscular Dystrophy? (2019) (0)
- Tolerance induction by fixed, Achr-targeted, antigen presenting B cells (1991) (0)
- [A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.]. (1976) (0)
- Nerve‐Muscle Interaction (1979) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Daniel b. Drachman?
Daniel b. Drachman is affiliated with the following schools:
